Press Releases reVision Therapeutics Announces License with Cornell University The deal relates to technology for treating Stargardt disease. Published 5 months ago on September 2, 2020 By INVISION Staff Share Tweet (PRESS RELEASE) RIDGEWOOD, NJ — reVision Therapeutics Inc., a privately held early stage biopharmaceutical company focused on the development and commercialization of innovative therapies for ocular and rare diseases, announced that it has signed an exclusive license agreement with Cornell University. The agreement is for the development and commercialization of Cornell’s proprietary technology for the treatment of Stargardt disease, a genetic disorder that affects central vision. “The Cornell license represents a significant milestone for reVision and underscores the Company’s commitment to innovative therapies and treatments for unmet medical needs associated with genetic and progressive vision loss,” said Paul Fehlner, reVision’s president and CEO. “We believe this will enable us to accelerate the development of our Stargardt disease treatment, which was the basis for founding reVision. We would like to congratulate the Cornell research team for their superb work in elucidating a novel mechanism of action to treat this devastating disease.” “We are pleased that reVision will develop a treatment option for Stargardt patients based on our scientific discoveries,” said Marcelo Nociari, PhD, assistant professor of Immunology in Ophthalmology, Weill Cornell Medical College, co-inventor of US Patent No. 10,463,687, which is part of the license agreement. “There are no current treatment options for Stargardt disease, which often manifests in childhood and leads to legal blindness within the second or third decade of life. reVision has assembled a team with proven expertise and passion for advancing life-changing eye therapies.” “This is an important opportunity for reVision to work with Cornell to find a treatment for retinal diseases like Stargardt,” said Brian Brooks, MD, PhD, of the National Eye Institute, a reVision scientific adviser. “With no approved treatment for Stargardt, we need to find ways to preserve vision and improve Stargardt patients’ quality of life.” Related Topics:Latest News TopreVision Therapeutics click to Comment(Comment) Up Next COVID-19 Face Masks Are Giving People Dry Eye, Experts Say Don't Miss INVISION Supports SECO International and National Academy of Opticianry in Expansion of Virtual Education for Opticians Advertisement SPONSORED VIDEO SPONSORED BY TOPCON HEALTHCARE Perform Refraction from Anywhere with RDx Now more than ever, you need to grow your practice beyond your physical location and deliver quality eye exams from virtually anywhere. Topcon RDx® is an innovative ocular telehealth platform that allows you to connect to your office remotely and conduct comprehensive eye exams, without sacrificing the quality care you provide. You may like Ophthalmologist Convicted of Fraud Could Receive Pardon from Trump Pacific Vision Surgery Center Opens Doors to Bay Area Community 2020 Holiday Sales Grew 8% Despite Pandemic, NRF Reports Promoted Headlines Ray-Ban® Authentic Essilor Get More with Essilor Essilor 360° SUPPORT. 365 DAYS A YEAR. Essilor Advertisement Latest Trending Videos Headlines1 day ago Ophthalmologist Convicted of Fraud Could Receive Pardon from Trump Press Releases1 day ago Pacific Vision Surgery Center Opens Doors to Bay Area Community Press Releases1 day ago 2020 Holiday Sales Grew 8% Despite Pandemic, NRF Reports Sponsored Content2 days ago Ray-Ban® Authentic Headlines3 days ago Eyecare Center Offers Free Laser Surgery for NFL Referee After Controversial Call America's Finest 2019 Entries2 weeks ago America’s Finest: Before You Start America's Finest 2019 Entries3 weeks ago America’s Finest: Get Your Contest Entry in Great Shape America's Finest 2019 Entries2 weeks ago America’s Finest: Basic Info and Stats America's Finest 2019 Entries2 weeks ago America’s Finest: You Gotta Stand Out from the Crowd America's Finest 2019 Entries2 weeks ago America’s Finest: Photos Really Are Worth at Least a Thousand Words Sponsored Content2 days ago Ray-Ban® Authentic Sponsored Content1 week ago Get More with Essilor Sponsored Content1 month ago Perform Refraction from Anywhere with RDx Headlines3 months ago Video: Florida Man Invents Robot to Place Contact Lenses Headlines3 months ago Video: Some Retailers Board Up Due to Election Unrest Fears Advertisement SubscribeBULLETINS Get the most important news and business ideas for eyecare professionals every weekday from INVISION. Advertisement Most Popular Photo Gallery1 week ago 12 Images That Show Why Zionsville Eyecare in Zionsville, IN, Was Named One of America’s Finest Optical Retailers Press Releases1 week ago EnChroma Names Vision Industry Veteran Erik Ritchie as CEO Headlines3 days ago Eyecare Center Offers Free Laser Surgery for NFL Referee After Controversial Call Headlines6 days ago Massachusetts ODs Win Right to Treat Glaucoma Sponsored Content1 week ago Get More with Essilor Columns6 days ago 2021 Is a New Year… Let’s Make Your Marketing New, Too! Press Releases1 week ago Eco Helps Trees for the Future Reach 200M Trees Sponsored Content1 week ago 360° SUPPORT. 365 DAYS A YEAR.